These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24469045)

  • 61. Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.
    Murata T; Kondo Y; Sugimoto A; Kawashima D; Saito S; Isomura H; Kanda T; Tsurumi T
    J Virol; 2012 May; 86(9):4752-61. PubMed ID: 22357272
    [TBL] [Abstract][Full Text] [Related]  

  • 62. No Easy Way Out for EZH2: Its Pleiotropic, Noncanonical Effects on Gene Regulation and Cellular Function.
    Wang J; Wang GG
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327550
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis.
    Coward WR; Brand OJ; Pasini A; Jenkins G; Knox AJ; Pang L
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):449-460. PubMed ID: 29053336
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Switching roles for DNA and histone methylation depend on evolutionary ages of human endogenous retroviruses.
    Ohtani H; Liu M; Zhou W; Liang G; Jones PA
    Genome Res; 2018 Aug; 28(8):1147-1157. PubMed ID: 29970451
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
    Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
    Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.
    Margueron R; Li G; Sarma K; Blais A; Zavadil J; Woodcock CL; Dynlacht BD; Reinberg D
    Mol Cell; 2008 Nov; 32(4):503-18. PubMed ID: 19026781
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
    Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
    J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
    [TBL] [Abstract][Full Text] [Related]  

  • 68. H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.
    Nichol JN; Dupéré-Richer D; Ezponda T; Licht JD; Miller WH
    Adv Cancer Res; 2016; 131():59-95. PubMed ID: 27451124
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The oncogenic polycomb histone methyltransferase EZH2 methylates lysine 120 on histone H2B and competes ubiquitination.
    Kogure M; Takawa M; Saloura V; Sone K; Piao L; Ueda K; Ibrahim R; Tsunoda T; Sugiyama M; Atomi Y; Nakamura Y; Hamamoto R
    Neoplasia; 2013 Nov; 15(11):1251-61. PubMed ID: 24339737
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Kicking against the PRCs - A Domesticated Transposase Antagonises Silencing Mediated by Polycomb Group Proteins and Is an Accessory Component of Polycomb Repressive Complex 2.
    Liang SC; Hartwig B; Perera P; Mora-García S; de Leau E; Thornton H; de Lima Alves F; Rappsilber J; Yang S; James GV; Schneeberger K; Finnegan EJ; Turck F; Goodrich J
    PLoS Genet; 2015 Dec; 11(12):e1005660. PubMed ID: 26642436
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantification of histone H3 Lys27 trimethylation (H3K27me3) by high-throughput microscopy enables cellular large-scale screening for small-molecule EZH2 inhibitors.
    Luense S; Denner P; Fernández-Montalván A; Hartung I; Husemann M; Stresemann C; Prechtl S
    J Biomol Screen; 2015 Feb; 20(2):190-201. PubMed ID: 25409661
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.
    Dal-Pra S; Hodgkinson CP; Mirotsou M; Kirste I; Dzau VJ
    Circ Res; 2017 Apr; 120(9):1403-1413. PubMed ID: 28209718
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
    Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H
    Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies.
    Khan SN; Jankowska AM; Mahfouz R; Dunbar AJ; Sugimoto Y; Hosono N; Hu Z; Cheriyath V; Vatolin S; Przychodzen B; Reu FJ; Saunthararajah Y; O'Keefe C; Sekeres MA; List AF; Moliterno AR; McDevitt MA; Maciejewski JP; Makishima H
    Leukemia; 2013 Jun; 27(6):1301-9. PubMed ID: 23486531
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epigenetic silencing of Bim transcription by Spi-1/PU.1 promotes apoptosis resistance in leukaemia.
    Ridinger-Saison M; Evanno E; Gallais I; Rimmelé P; Selimoglu-Buet D; Sapharikas E; Moreau-Gachelin F; Guillouf C
    Cell Death Differ; 2013 Sep; 20(9):1268-78. PubMed ID: 23852375
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation.
    Lorzadeh A; Romero-Wolf M; Goel A; Jadhav U
    Gastroenterology; 2021 Jun; 160(7):2267-2282. PubMed ID: 33775639
    [TBL] [Abstract][Full Text] [Related]  

  • 77. JMJD3 as an epigenetic regulator in development and disease.
    Burchfield JS; Li Q; Wang HY; Wang RF
    Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
    [TBL] [Abstract][Full Text] [Related]  

  • 78. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
    Mu W; Starmer J; Yee D; Magnuson T
    Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase.
    Ott M; Litzenburger UM; Sahm F; Rauschenbach KJ; Tudoran R; Hartmann C; Marquez VE; von Deimling A; Wick W; Platten M
    PLoS One; 2012; 7(10):e47663. PubMed ID: 23077658
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PALI1 promotes tumor growth through competitive recruitment of PRC2 to G9A-target chromatin for dual epigenetic silencing.
    Fong KW; Zhao JC; Lu X; Kim J; Piunti A; Shilatifard A; Yu J
    Mol Cell; 2022 Dec; 82(24):4611-4626.e7. PubMed ID: 36476474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.